A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Seer, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 600 shares of SEER stock, worth $1,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 100 500.0%
Holding current value
$1,386
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.59 - $2.07 $82,751 - $107,733
-52,045 Reduced 15.1%
292,671 $573,000
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.24 $93,147 - $126,454
56,453 Added 19.58%
344,716 $579,000
Q1 2024

May 15, 2024

BUY
$1.54 - $2.09 $208,317 - $282,716
135,271 Added 88.42%
288,263 $547,000
Q4 2023

Feb 14, 2024

BUY
$1.47 - $2.22 $187,736 - $283,520
127,712 Added 505.19%
152,992 $296,000
Q3 2023

Nov 14, 2023

SELL
$2.18 - $5.52 $1.25 Million - $3.15 Million
-571,523 Reduced 95.76%
25,280 $55,000
Q2 2023

Aug 14, 2023

BUY
$3.16 - $4.96 $1.76 Million - $2.76 Million
555,470 Added 1343.89%
596,803 $2.55 Million
Q1 2023

May 15, 2023

SELL
$3.6 - $5.88 $275,050 - $449,249
-76,403 Reduced 64.89%
41,333 $159,000
Q4 2022

Feb 14, 2023

BUY
$5.03 - $8.58 $339,585 - $579,252
67,512 Added 134.42%
117,736 $682,000
Q3 2022

Nov 14, 2022

BUY
$7.7 - $13.31 $386,724 - $668,481
50,224 New
50,224 $389,000
Q1 2022

May 16, 2022

BUY
$11.88 - $23.4 $746,848 - $1.47 Million
62,866 Added 137.15%
108,702 $1.66 Million
Q4 2021

Feb 14, 2022

BUY
$21.08 - $38.51 $836,686 - $1.53 Million
39,691 Added 645.91%
45,836 $1.05 Million
Q3 2021

Nov 15, 2021

SELL
$27.67 - $45.04 $1.39 Million - $2.26 Million
-50,119 Reduced 89.08%
6,145 $212,000
Q2 2021

Aug 16, 2021

SELL
$28.75 - $56.92 $4.06 Million - $8.05 Million
-141,343 Reduced 71.53%
56,264 $1.84 Million
Q4 2020

Feb 16, 2021

BUY
$55.23 - $81.11 $10.9 Million - $16 Million
197,607 New
197,607 $11.1 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $135M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.